Survivorship in Patients Receiving Immune Checkpoint Inhibitors

Disease Sites:

Miscellaneous

Staging:

N/A

Age Group:

Adults

Therapies:

Not Available

Drugs:

Not Available

Principal Investigator(s):

Johnson, Douglas

Scope:

Local

Participating Institutions:

Dana-Farber Cancer Institute, Mayo Clinic - Jacksonville, Vanderbilt University

Open Date:

06-23-2015

Objective:

Survivorship in Patients Receiving Immune Checkpoint Inhibitors

Trial Type:

Other

Protocol ID:

VICCMEL15138

Eligibility

Ages Eligible for Study:

Not Available

Genders Eligible for Study:

Not Available

Accepts Healthy Volunteers?:

Not Available